Sassun Richard, Larson David W, Sileo Annaclara, Ng Jyi Cheng, Ferrari Davide, McKenna Nicholas P, Perry William R G
Division of Colon and Rectal Surgery, Mayo Clinic, 200 First St. Southwest, Rochester, MN, 55905, USA.
Int J Colorectal Dis. 2025 Apr 22;40(1):99. doi: 10.1007/s00384-025-04861-6.
Anorectal melanoma (ARM) poses a significant challenge due to the lack of established guidelines and a 5-year overall survival rate of less than 20%. The only recognized death risk factors are positive lymph nodes and positive surgical margins. This study aimed to identify the risk factors for local/distant recurrences and death in a 22-year multi-institutional experience.
All patients who underwent curative surgical resection or were referred to after resection at the Mayo Clinic for non-metastatic ARM (2002-2024) were included. Risk factors for local/distant recurrences, and deaths were assessed through multivariable Cox regression.
Eighty-eight patients were included in the study. Seventy-eight percent of patients had anal melanoma and 22% rectal melanoma. Nineteen percent had clinically positive lymph nodes. The surgical margins were positive in 62% of local surgeries, while they were positive in 13% of radical surgery cases. The first recurrence was often a local recurrence (67%), followed by distant metastasis (21%), with an overall comparable overall survival between the two. Radiotherapy administration, radical surgery, and negative margins were associated with less local recurrence. Clinically positive lymph nodes and local recurrences increased the risk of developing distant metastasis over time. Clinically negative lymph nodes, radiotherapy administration, radical surgery, and negative margins all contributed to a reduced death risk.
Local recurrences in ARM may influence distant metastasis and death more than what was previously believed. Positive surgical margins in local surgery were remarkably high, reaching 62%. Protective factors for local recurrence and death included radical surgery, negative surgical margins, and radiotherapy.
由于缺乏既定指南且5年总生存率低于20%,肛管直肠黑色素瘤(ARM)带来了重大挑战。唯一公认的死亡风险因素是淋巴结阳性和手术切缘阳性。本研究旨在通过一项为期22年的多机构经验,确定局部/远处复发及死亡的风险因素。
纳入所有在梅奥诊所接受根治性手术切除或切除术后因非转移性ARM前来就诊的患者(2002 - 2024年)。通过多变量Cox回归评估局部/远处复发及死亡的风险因素。
88例患者纳入研究。78%的患者为肛管黑色素瘤,22%为直肠黑色素瘤。19%的患者临床淋巴结阳性。局部手术中62%的手术切缘阳性,而根治性手术病例中13%的手术切缘阳性。首次复发通常为局部复发(67%),其次是远处转移(21%),两者的总生存率总体相当。放疗、根治性手术和切缘阴性与局部复发较少相关。随着时间推移,临床淋巴结阳性和局部复发会增加发生远处转移的风险。临床淋巴结阴性、放疗、根治性手术和切缘阴性均有助于降低死亡风险。
ARM的局部复发对远处转移和死亡的影响可能比之前认为的更大。局部手术中手术切缘阳性率极高,达62%。局部复发和死亡的保护因素包括根治性手术、手术切缘阴性和放疗。